Methenolone Enanthate: Complete Guide to the Raw Anabolic Compound

Introduction

Methenolone Enanthate is a meticulously synthesized anabolic-androgenic steroid that has garnered significant attention in the realms of clinical therapy, athletic performance, and scientific research. As a long-esterified derivative of methenolone, the active base hormone is esterified with enanthic acid at the 17β-hydroxyl position, resulting in a compound with a prolonged half-life and a sustained release profile. This chemical modification allows for less frequent administration while maintaining stable physiological levels of the active hormone. At Wholesale China Peptides, we understand that sourcing high-quality raw compounds demands rigorous analytical verification, transparent chemical documentation, and uncompromising purity standards. Our Methenolone Enanthate product embodies these principles, offering researchers, clinicians, and industry professionals a premium-grade raw peptide that meets the most stringent pharmacopeial requirements. This exhaustive guide provides an in-depth exploration of the chemical structure, composition, pharmacological properties, therapeutic applications, safety considerations, and quality assurance protocols associated with Methenolone Enanthate, ensuring you have all the information necessary to make informed decisions for your research, formulation, or clinical needs.

Chemical Information and Molecular Structure

Chemical nomenclature and classification

Methenolone Enanthate, chemically designated as 1-methyl-17β-hydroxyandrost-4-en-3-one enanthate, belongs to the class of synthetic androgenic-anabolic steroids. It is a semi-synthetic derivative of testosterone, with a methyl group added at the 1-position of the A-ring, which enhances its anabolic potency while reducing aromatization. The compound features the characteristic cyclopentanoperhydrophenanthrene ring system typical of steroids, with a ketone group at the 3-position, a double bond between carbons 4 and 5, and a hydroxyl group at the 17β position. The 17β-hydroxyl group is esterified with enanthic acid, a straight-chain seven-carbon fatty acid (heptanoic acid), forming the enanthate ester. This esterification is the defining feature that imparts the compound’s long-acting properties.

The classification of Methenolone Enanthate as an anabolic-androgenic steroid places it in a category of compounds that bind to intracellular androgen receptors, modulating gene expression and promoting protein synthesis. Its unique structural features distinguish it from other steroids such as testosterone, nandrolone, or stanozolol, and confer a distinct pharmacological profile characterized by high anabolic potency, low estrogenic activity, and moderate androgenic effects.

Molecular formula and physical properties

The molecular formula of Methenolone Enanthate is C27H42O3, with a molecular weight of 414.6 g/mol. In its pure form, the compound appears as a white to off-white crystalline powder, characterized by a high degree of structural order and lattice stability. The melting point of Methenolone Enanthate is typically reported in the range of 125-130°C, reflecting its thermal stability and pure crystalline nature. The compound exhibits specific optical rotation, and its density falls within the range of 1.05-1.10 g/cm³.

Methenolone Enanthate is highly lipophilic, with a log P (partition coefficient) estimated to be around 4.0-4.5, indicating a strong preference for lipid environments. This high lipophilicity is directly responsible for the compound’s slow release from intramuscular injection sites and its extended duration of action. The compound is practically insoluble in water and must be dissolved in suitable oil-based solvents, such as sesame oil or cottonseed oil, for injectable formulations. It is stable under normal atmospheric conditions but should be protected from light, moisture, and excessive heat to maintain its integrity over time.

Stereochemistry and isomeric purity

The stereochemical configuration of Methenolone Enanthate is critical to its biological activity. The compound is synthesized with the natural (17β)-hydroxyl orientation, and the enanthate ester is attached to this hydroxyl group without introducing any additional chiral centers. The double bond at the 4,5-position is in the Δ4 configuration, and the 1-methyl group is typically in the α-configuration, though the stereochemistry is controlled to ensure uniformity. The enanthate chain is a straight-chain saturated fatty acid, so it does not introduce any stereochemical complexity.

Our manufacturing process employs advanced chiral separation and purification techniques, such as preparative high-performance liquid chromatography (HPLC) and recrystallization, to achieve stereochemical purity exceeding 99%, ensuring that the compound exhibits predictable and consistent biological activity. Any isomeric impurities, such as the 17α-epimer or 1-epimer, are rigorously minimized to meet pharmacopeial standards.

Composition and Formulation

Active pharmaceutical ingredient

The primary active component in our Methenolone Enanthate product is the pure steroid compound itself, designated as Methenolone Enanthate with a minimum potency of 98% by high-performance liquid chromatography (HPLC) analysis. This high percentage of active ingredient ensures consistent dosing and predictable pharmacological effects. The compound is supplied as a lyophilized powder or crystalline solid, depending on the specific formulation requirements of the customer. For research purposes, we also offer the compound in powder form without excipients, allowing customers to formulate the product according to their own specifications.

The active ingredient undergoes comprehensive analytical verification using a suite of advanced techniques including HPLC, mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and elemental analysis. These analyses collectively confirm the identity, purity, and structural integrity of the Methenolone Enanthate molecules in each batch, providing full transparency and assurance of quality.

Excipients and formulation components

The formulation of Methenolone Enanthate may include various excipients depending on the intended route of administration and storage requirements. For injectable preparations, the compound is typically dissolved in a vehicle such as sesame oil or cottonseed oil. These oil vehicles are selected for their biocompatibility, stability, and ability to solubilize the highly lipophilic ester compound effectively. The oil is usually sterilized by filtration or autoclaving to ensure sterility.

When supplied as a lyophilized powder, the formulation may include buffer salts such as sodium phosphate or glycine to maintain pH stability and prevent degradation during the lyophilization process. Antimicrobial preservatives, such as benzyl alcohol or phenol, may be added in multi-dose formulations to prevent bacterial contamination. For research applications, we can provide the compound in a pure, excipient-free form, allowing researchers to reconstitute it with their preferred solvent and concentration.

Purity specifications and quality markers

Our Methenolone Enanthate meets or exceeds pharmacopeial standards for raw steroid compounds. The purity specification is typically ≥98% by HPLC, with residual solvent content below acceptable limits as defined by ICH guidelines. Heavy metal content is maintained below 10 ppm for lead, 2 ppm for cadmium, and 1 ppm for mercury, ensuring the compound is suitable for pharmaceutical and research applications.

Microbiological limits include total aerobic microbial count below 1000 CFU/g, total yeast and mold count below 100 CFU/g, and absence of E. coli, Salmonella, and Staphylococcus aureus. These stringent quality markers ensure that the compound is safe for use in sensitive applications and complies with international pharmaceutical standards. Additionally, we test for residual starting materials and byproducts to ensure that the final product is free from potentially harmful impurities.

Pharmacological Profile

Mechanism of action

Methenolone Enanthate functions as a prodrug that undergoes hydrolysis in vivo to release active methenolone and enanthic acid. The esterification at the 17β position serves as a delivery mechanism that modulates the release kinetics of the active hormone. Upon intramuscular injection, the compound forms a depot at the injection site, from which it is gradually released into the systemic circulation. The slow release profile is a result of the compound’s high lipophilicity, which promotes retention within the lipid-rich muscle tissue.

Macrophages and other tissue cells gradually metabolize the ester bond through esterase enzymes, releasing methenolone in a sustained manner over an extended period. This prolonged release mechanism provides stable physiological levels of methenolone, minimizing the peaks and troughs associated with shorter-esterified anabolic steroids. The steady release of methenolone allows for consistent anabolic activity, making Methenolone Enanthate a valuable tool for both clinical and research applications.

Methenolone itself is a potent androgen that binds with high affinity to androgen receptors, forming a hormone-receptor complex that translocates to the nucleus and modulates gene expression. This genomic action leads to increased protein synthesis, nitrogen retention, and erythropoiesis. The compound also exhibits non-genomic effects, including rapid activation of signaling pathways that contribute to its anabolic and androgenic properties. The 1-methyl substitution and the absence of a 19-methyl group (it is a 19-nor? Actually, methenolone is not 19-nor; it retains the C19 methyl, but the 1-methyl substitution is the key) enhance its anabolic potency while reducing estrogenic activity, as methenolone is not aromatized to estradiol.

Pharmacokinetic parameters

The pharmacokinetic profile of Methenolone Enanthate is characterized by a prolonged absorption phase and an extended elimination half-life. After intramuscular injection, the compound is gradually absorbed from the injection site, with peak plasma concentrations typically occurring within 2-3 days post-administration. The half-life of Methenolone Enanthate in humans is approximately 4-5 days, though this can vary based on individual metabolic factors, injection technique, and the specific formulation used.

The volume of distribution is relatively large, reflecting the compound’s extensive tissue distribution and binding to sex hormone-binding globulin (SHBG) and albumin. Protein binding is approximately 95-98%, with the bound fraction serving as a reservoir that further extends the compound’s duration of action. Only a small fraction of the total circulating compound is present as free methenolone, but this free fraction represents the biologically active portion that exerts androgenic effects. The large volume of distribution and high protein binding contribute to the compound’s long half-life and sustained pharmacological activity.

Metabolic pathway

The metabolism of Methenolone Enanthate involves hydrolysis of the ester bond by various esterases located in plasma, liver, and peripheral tissues. This hydrolysis releases methenolone and enanthic acid as the primary metabolites. Methenolone then undergoes further metabolism through multiple pathways, including reduction of the 4,5-double bond, hydroxylation, and conjugation reactions (glucuronidation and sulfation) that facilitate excretion.

The enanthic acid moiety is metabolized through beta-oxidation pathways similar to fatty acid metabolism, ultimately yielding carbon dioxide and water as end products. This metabolic pathway ensures that the ester component does not accumulate in the body and is efficiently eliminated. Methenolone itself is not aromatized to estrogens, which minimizes estrogen-related side effects. However, it can be metabolized to other androgenic compounds that may contribute to its potent anabolic effects.

Therapeutic Applications and Research Uses

Clinical applications

Methenolone Enanthate has been utilized in clinical settings for the treatment of muscle wasting, HIV-associated cachexia, and other conditions associated with negative nitrogen balance. The prolonged release profile makes it suitable for maintenance therapy in patients requiring consistent anabolic support over extended periods. The compound has been used in the management of delayed puberty in males, osteoporosis associated with androgen deficiency, and chronic wounds, although these uses are less common today due to the availability of more targeted therapies.

In veterinary medicine, Methenolone Enanthate is sometimes used to promote weight gain and muscle mass in livestock, though its use is less common than other steroids. Its application in veterinary practice must be conducted under the guidance of a licensed veterinarian and in compliance with regulatory requirements.

In clinical practice, the compound is administered via intramuscular injection, typically in the gluteal muscle, with dosing intervals ranging from once weekly to once every two weeks depending on the therapeutic indication and patient response. The extended release characteristics allow for less frequent dosing compared to shorter-acting anabolic steroids, improving patient compliance and convenience.

Research applications

In the research domain, Methenolone Enanthate serves as a valuable tool for studying androgen biology, reproductive physiology, and related pharmacological processes. Researchers utilize the compound to investigate the effects of sustained androgen exposure on various physiological systems, including musculoskeletal, cardiovascular, and hematological systems. The prolonged release profile allows for the study of chronic anabolic effects without the need for frequent injections.

The compound is also employed in studies examining the structure-activity relationships of anabolic steroids, providing insights into how chemical modifications affect pharmacokinetic properties and biological activity. Additionally, Methenolone Enanthate is used in animal models to induce anabolic effects and study the compound’s impact on various disease states and physiological parameters. Its stability and predictable release make it a preferred choice for long-term studies.

Benefits and Advantages

Prolonged duration of action

One of the primary advantages of Methenolone Enanthate is its extended duration of action, which results from the slow release of the active hormone from the injection site. This prolonged release profile provides stable anabolic support over an extended period, reducing the need for frequent injections and maintaining consistent physiological levels of methenolone. The extended half-life of 4-5 days allows for dosing intervals of one to two weeks, which is particularly beneficial for patients and researchers who prefer less frequent administration.

The sustained release characteristics also contribute to more stable hormonal balance, minimizing the fluctuations that can occur with shorter-acting compounds. This stability is particularly beneficial for individuals seeking consistent anabolic effects and those who prefer a less frequent dosing schedule.

Enhanced lipid solubility

The enanthate ester chain significantly enhances the lipid solubility of the methenolone molecule, enabling better retention within muscle tissue and slower absorption into the bloodstream. This enhanced lipophilicity is the key factor behind the compound’s extended half-life and prolonged duration of action. The improved lipid solubility also facilitates the compound’s distribution into various tissues, allowing it to exert its effects across multiple physiological systems.

The broad tissue distribution contributes to the compound’s comprehensive anabolic activity, making it effective for both local and systemic applications. The lipophilic nature also allows for the creation of stable oil-based formulations that are easy to administer and store.

High anabolic potency with low estrogenic activity

Methenolone Enanthate is renowned for its potent anabolic effects, which promote protein synthesis and nitrogen retention more effectively than many other anabolic steroids. This makes it particularly valuable for treating conditions characterized by muscle wasting and negative nitrogen balance. The compound’s ability to stimulate erythropoiesis is another significant benefit, making it a historical treatment for anemia and a research tool for studying red blood cell production.

Unlike many anabolic steroids, Methenolone Enanthate is not aromatized to estradiol, which means it does not convert to estrogen in the body. This reduces the risk of estrogen-related side effects such as gynecomastia, water retention, and increased blood pressure. The low estrogenic activity makes it a preferred choice for individuals seeking to avoid these side effects.

Favorable androgenic profile

While Methenolone Enanthate is highly anabolic, it exhibits moderate androgenic activity, which contributes to its effectiveness in promoting muscle growth and masculine traits without excessive androgenic side effects such as severe acne or prostate enlargement. This balanced profile makes it suitable for a wide range of users, including those who are sensitive to high-androgen compounds.

Dosage and Administration Guidelines

General dosing considerations

The appropriate dosage of Methenolone Enanthate depends on various factors, including the individual’s age, weight, therapeutic indication, and treatment goals. In clinical practice, dosing for muscle wasting or cachexia typically ranges from 200-400 mg per week, divided into one or two injections, with adjustments based on individual response and tolerance. For research applications, dosing protocols vary widely; common regimens in animal models range from 0.5-2 mg per kg body weight per week, depending on the species and study objectives.

It is crucial to monitor liver function tests, hematocrit, and lipid profiles regularly, as Methenolone Enanthate can cause hepatotoxicity and erythrocytosis. Dosage should be adjusted accordingly to avoid adverse effects.

Administration route and technique

Methenolone Enanthate is administered via deep intramuscular injection, typically into the gluteal muscle or the vastus lateralis muscle. The compound should be administered slowly to minimize discomfort and ensure proper distribution within the muscle tissue. The injection site should be rotated to prevent local tissue damage and ensure consistent absorption.

The compound should be administered using sterile technique to prevent infection. The injection should be performed at a 90-degree angle into the muscle, and aspiration should be performed to ensure the needle is not within a blood vessel before injection. If the compound is supplied as a powder, it must be reconstituted with the appropriate solvent (e.g., sterile water for injection) according to the manufacturer’s instructions before use.

Monitoring and adjustments

Regular monitoring of physiological parameters is essential when using Methenolone Enanthate. This includes measurement of serum methenolone levels, hematocrit, lipid profiles, liver function tests, and blood pressure. In male patients, prostate-specific antigen (PSA) and digital rectal examination should be performed to monitor for prostate enlargement. Additional monitoring may include bone mineral density, body composition, and mood changes.

Dosage adjustments may be necessary based on individual response and tolerance. If adverse effects such as hepatotoxicity, jaundice, or severe acne occur, the dosing interval may be extended or the dose reduced. In research settings, regular monitoring of body weight, blood chemistry, and behavioral changes is recommended to assess the compound’s effects and ensure animal welfare.

Safety and Considerations

Contraindications and precautions

Methenolone Enanthate is contraindicated in individuals with a history of prostate cancer, breast cancer, or other androgen-sensitive malignancies. The compound should not be used by individuals with uncontrolled cardiovascular disease, severe hepatic impairment, or uncontrolled erythrocytosis (hematocrit >50%).

Pregnant and breastfeeding women should avoid exposure to the compound, as androgenic agents can cause fetal virilization and other developmental effects. The compound should be used with caution in individuals with a history of psychiatric disorders, as anabolic steroids can affect mood and behavior. Additionally, individuals with a history of thromboembolic disorders or those at high risk for cardiovascular events should be closely monitored.

Potential side effects

The use of Methenolone Enanthate can be associated with various side effects, including acne, oily skin, hair loss (androgenic alopecia), increased body hair, changes in libido, and mood alterations (aggression, irritability). Other potential side effects include hepatotoxicity (elevated liver enzymes, cholestatic jaundice), fluid retention, increased blood pressure, changes in lipid profiles (decrease in HDL, increase in LDL), erythrocytosis, and gynecomastia. In severe cases, liver damage such as peliosis hepatis or hepatic adenoma may occur.

Most side effects are dose-dependent and reversible upon dose reduction or discontinuation of the compound. However, some effects such as hair loss and prostate enlargement may be irreversible in some individuals. Regular monitoring and prompt reporting of any adverse effects are essential to minimize risks.

Drug interactions

Methenolone Enanthate may interact with various medications, including anticoagulants (e.g., warfarin), insulin and oral hypoglycemic agents, and corticosteroids. The compound may potentiate the effects of anticoagulants, increasing the risk of bleeding. Close monitoring of coagulation parameters is required when the compound is used concomitantly with these medications.

The compound may also interact with other androgenic agents, including anabolic steroids and supplements, potentially increasing the risk of adverse effects. Individuals should disclose all medications and supplements to their healthcare provider before initiating Methenolone Enanthate therapy. Additionally, the compound may interfere with certain laboratory tests, such as thyroid function tests, so appropriate caution should be exercised.

Quality Assurance and Manufacturing

Manufacturing standards

Our Methenolone Enanthate is manufactured under current Good Manufacturing Practices (cGMP) and complies with international pharmaceutical quality standards. The manufacturing facility is equipped with advanced analytical instrumentation and employs trained personnel trained in quality control procedures. The facility is regularly audited to ensure compliance with regulatory requirements.

The manufacturing process includes multiple stages of purification and quality verification to ensure the compound meets stringent purity and potency specifications. Each batch undergoes comprehensive analytical testing to verify identity, purity, and structural integrity. The process is designed to minimize the risk of contamination and ensure consistent product quality.

Analytical verification

Each batch of Methenolone Enanthate is analyzed using a comprehensive suite of analytical techniques including HPLC, mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and elemental analysis. These analyses confirm the compound’s identity, purity, and structural characteristics, ensuring consistency across all batches. The HPLC analysis provides a purity profile and quantitative assay, while mass spectrometry confirms the molecular weight and fragmentation pattern. NMR spectroscopy provides detailed information about the chemical structure and stereochemistry.

The analytical report includes detailed results for each parameter, providing full transparency regarding the quality of the product. Customers can request copies of the analytical reports for their orders, ensuring they have the information necessary to verify the quality of the compound. We also perform stability testing to ensure the compound maintains its potency and purity over its shelf life.

Storage and stability

Methenolone Enanthate should be stored in a cool, dry place, protected from light and moisture. The compound should be stored at temperatures between 2-8°C for long-term storage, although it can be stored at room temperature for short periods. The compound should be kept in its original packaging until ready for use. For the powder form, the vial should be tightly sealed to prevent moisture absorption.

The compound demonstrates good stability under recommended storage conditions, with a shelf life of typically 2-3 years from the date of manufacture. Regular inspection of the compound for signs of degradation, such as discoloration or clumping, should be performed before use. If any abnormalities are observed, the product should not be used.

Ordering and Wholesale Information

Product specifications

Our Methenolone Enanthate is available in various quantities to meet the needs of different customers, from research samples to bulk wholesale orders. The compound is offered in powder form with purity ≥98% by HPLC, or in pre-formulated injectable solutions upon request. Each order includes a comprehensive analytical report verifying the compound’s quality and specifications.

Custom formulations and packaging options are available for bulk orders, allowing customers to specify their exact requirements, such as specific concentrations, solvent types, or vial sizes. We work closely with customers to ensure that the product meets their precise needs.

Pricing and availability

Pricing for Methenolone Enanthate is competitive and based on order quantity. Bulk wholesale orders receive preferential pricing, reflecting the economies of scale achieved in our manufacturing and distribution operations. The compound is regularly stocked, ensuring timely delivery for both sample and bulk orders. We offer flexible pricing tiers to accommodate different budget requirements.

We offer various payment options including wire transfer, credit card, and secure online payment platforms. International shipping is available, with discreet packaging and full tracking for all orders. Our logistics team ensures that the product is handled properly to maintain its integrity during transit.

Customer support

Our team of experienced professionals is available to assist customers with any questions or requirements regarding Methenolone Enanthate. We provide technical support, analytical documentation, and ordering assistance to ensure a seamless purchasing experience. Our support team is knowledgeable about steroid chemistry and can provide guidance on formulation, storage, and usage.

Custom requests, including specific purity requirements, packaging formats, and formulation assistance, are accommodated whenever possible. We strive to build long-term partnerships with our customers based on trust, quality, and exceptional service. We are committed to being your reliable partner in sourcing high-quality raw compounds.

Frequently Asked Questions

What is Methenolone Enanthate?

Methenolone Enanthate is a long-esterified anabolic-androgenic steroid derivative in which the 17β-hydroxyl group of methenolone is esterified with enanthic acid. This chemical modification enhances the compound’s lipophilicity and extends its half-life, resulting in a prolonged release profile that makes it suitable for both clinical and research applications.

How does Methenolone Enanthate differ from other anabolic steroids?

The primary differences are its 1-methyl substitution, which enhances anabolic potency, and its enanthate ester, which gives it a long half-life. Unlike many steroids, it is not aromatized to estradiol, reducing estrogenic side effects. It is also known for its potent anabolic activity and relatively low androgenic activity compared to its anabolic potency.

What is the typical half-life of Methenolone Enanthate?

The half-life of Methenolone Enanthate in humans is approximately 4-5 days, though this can vary based on individual metabolic factors and injection technique. The extended half-life is a result of the compound’s high lipophilicity and slow release from the injection site, allowing for less frequent dosing.

Is Methenolone Enanthate suitable for research use?

Yes, Methenolone Enanthate is widely used in research applications to study anabolic biology, pharmacokinetics, and related physiological processes. The compound is available in research-grade formulations suitable for in vitro and in vivo studies. Its prolonged release profile makes it ideal for long-term studies.

How should Methenolone Enanthate be stored?

The compound should be stored in a cool, dry place, protected from light and moisture. For long-term storage, temperatures between 2-8°C are recommended. Keep in the original packaging until ready for use.

What purity level do you offer for Methenolone Enanthate?

Our Methenolone Enanthate is offered with a purity of ≥98% by HPLC, meeting stringent pharmaceutical quality standards. Each batch undergoes comprehensive analytical testing to verify purity and identity.

Can you provide analytical reports for Methenolone Enanthate?

Yes, each batch of Methenolone Enanthate is accompanied by a comprehensive analytical report detailing the results of identity, purity, and structural integrity testing. Reports are available upon request.

What are the common side effects of Methenolone Enanthate?

Common side effects include acne, oily skin, hair loss, increased body hair, changes in libido, and mood alterations. Hepatotoxicity, fluid retention, and changes in lipid profiles are also possible. Most side effects are dose-dependent and reversible.

Is Methenolone Enanthate legal?

The legal status of Methenolone Enanthate varies by jurisdiction. In many countries, it is classified as a controlled substance or prescription medication. Individuals should verify the legal status in their jurisdiction before purchasing or using the compound. For research purposes, it is typically available under appropriate licenses.

Can Methenolone Enanthate be used in veterinary applications?

Methenolone Enanthate has been used in veterinary medicine for the treatment of muscle wasting and anemia in animals, and as a growth promoter in livestock under veterinary supervision. It is not approved for use in food-producing animals in many jurisdictions.

What is the molecular weight of Methenolone Enanthate?

The molecular weight of Methenolone Enanthate is 414.6 g/mol, with a molecular formula of C27H42O3. The compound is a white to off-white crystalline powder with a melting point of 125-130°C.

---

Conclusion

Methenolone Enanthate represents a potent and versatile compound within the realm of synthetic steroids, offering strong anabolic and androgenic effects with a prolonged release profile. At Wholesale China Peptides, we are committed to providing high-quality raw compounds that meet the exacting standards of researchers, clinicians, and industry professionals. Our Methenolone Enanthate product exemplifies our dedication to purity, potency, and comprehensive quality verification.

Whether you are conducting research, developing formulations, or seeking a reliable source of premium-grade steroids, our team is ready to assist you. We offer competitive wholesale pricing, comprehensive analytical documentation, and exceptional customer support to ensure your needs are met. Explore our full range of compound products and discover why our customers trust us as their preferred supplier for high-quality raw materials.

For inquiries, orders, or technical support, please contact our team at Wholesale China Peptides. We look forward to serving your compound supply needs with professionalism, quality, and reliability.